Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: DBLT Desferrioxamine Mesylate for Injection BP
Active Ingredient: Deferoxamine mesilate 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Hospira Australia Pty Limited, Melbourne, Australia
Product: DBLT Desferrioxamine Mesylate for Injection BP
Active Ingredient: Deferoxamine mesilate 2g
Dosage Form: Powder for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Hospira Australia Pty Limited, Melbourne, Australia
Dated this 11th day of September 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).